SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the Ninth Annual JMP Securities Research Conference on Wednesday, May 12, 2010 at 11:00 a.m. Pacific Time at The Ritz-Carlton Hotel in San Francisco.
